Amicus to sell gene therapy unit to Perceptive Advisors-backed SPAC
Amicus Therapeutics Inc has agreed to sell its gene therapy unit to ARYA Sciences Corp IV, a blank check company backed by Perceptive Advisors.
30 September 2021•8 mins read
Amicus Therapeutics Inc has agreed to sell its gene therapy unit to ARYA Sciences Corp IV, a blank check company backed by Perceptive Advisors.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
16 hours ago · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
16 hours ago · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
16 hours ago · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
17 hours ago · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
17 hours ago · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
17 hours ago · 1 min read
PE targets identity security as AI transforms threats: 6 deals
19 hours ago · 3 mins read
